Rovin Capital’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,700
Closed -$213K 196
2025
Q2
$213K Buy
2,700
+400
+17% +$32.3K 0.06% 180
2025
Q1
$245K Sell
2,300
-128
-5% -$13.6K 0.08% 165
2024
Q4
$224K Buy
2,428
+841
+53% +$94.7K 0.08% 156
2024
Q3
$211K Sell
1,587
-636
-29% -$81.9K 0.08% 162
2024
Q2
$260K Buy
2,223
+315
+17% +$35.5K 0.11% 141
2024
Q1
$239K Buy
+1,908
New +$222K 0.1% 144

Other funds holding CURE

Rovin Capital's CURE Position: Q3 2025 in Review

Rovin Capital sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q3 2025, closing a stake of 2,700 shares — an estimated $213K sold.

Rovin Capital first reported a position in CURE in Q1 2024 and held it in 6 quarters. The position peaked at $260K in Q2 2024. 22 funds tracked by Wall St. Rank hold CURE as of Q3 2025.

  • Rovin Capital reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q3 2025 after selling out during the quarter.
  • Rovin Capital sold 2,700 Direxion Daily Healthcare Bull 3X ETF shares in Q3 2025, an estimated $213K.
  • Rovin Capital first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2024 and held it in 6 quarters.
  • Rovin Capital's Direxion Daily Healthcare Bull 3X ETF position peaked at $260K in Q2 2024.
  • 22 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q3 2025.

Based on Rovin Capital's 13F filing for Q3 2025, filed 17 Oct 2025.